Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) saw unusually-high trading volume on Monday. 14,270 shares traded hands during trading, an increase of 166% from the average daily volume of 5,357 shares. The stock last traded at $26.00 and had previously closed at $25.0115.
Wall Street Analyst Weigh In
Separately, Zacks Research raised WuXi AppTec from a “hold” rating to a “strong-buy” rating in a report on Tuesday, November 3rd. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Strong Buy”.
Get Our Latest Report on WuXi AppTec
WuXi AppTec Stock Down 2.7%
The business has a fifty day simple moving average of $25.44 and a 200 day simple moving average of $19.58.
WuXi AppTec Company Profile
WuXi AppTec is a contract research, development and manufacturing services provider for the pharmaceutical and biotechnology industries. Founded in 2000 and headquartered in Shanghai, the company supports clients in developing medicines and bringing them through stages of research, testing and production. Its services include drug discovery and development, laboratory testing, clinical research support and manufacturing. WuXi AppTec works across small-molecule and other therapeutic development, providing services intended to help clients advance programs from early research toward commercialization.
Featured Articles
- Five stocks we like better than WuXi AppTec
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
